Larry Biegelsen
Stock Analyst at Wells Fargo
(3.74)
# 761
Out of 4,981 analysts
331
Total ratings
54.01%
Success rate
6.41%
Average return
Main Sectors:
Stocks Rated by Larry Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COO The Cooper Companies | Maintains: Overweight | $93 → $72 | $68.46 | +5.17% | 18 | Aug 28, 2025 | |
| MDT Medtronic | Maintains: Overweight | $98 → $100 | $94.25 | +6.10% | 18 | Aug 20, 2025 | |
| HYPR Hyperfine | Maintains: Equal-Weight | $0.68 → $0.85 | $1.35 | -37.04% | 6 | Aug 15, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Equal-Weight | $20 → $13 | $12.79 | +1.64% | 10 | Aug 7, 2025 | |
| EW Edwards Lifesciences | Maintains: Overweight | $84 → $88 | $78.01 | +12.81% | 17 | Aug 7, 2025 | |
| ALC Alcon | Reinstates: Equal-Weight | $93 | $79.68 | +16.72% | 9 | Aug 6, 2025 | |
| INSP Inspire Medical Systems | Maintains: Equal-Weight | $174 → $101 | $82.80 | +21.98% | 13 | Aug 5, 2025 | |
| SYK Stryker | Maintains: Overweight | $435 → $445 | $388.79 | +14.46% | 16 | Aug 1, 2025 | |
| TFX Teleflex | Maintains: Equal-Weight | $137 → $131 | $132.50 | -1.13% | 6 | Aug 1, 2025 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $6 → $3 | $1.69 | +77.51% | 7 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $24 | $24.49 | -2.00% | 17 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $86 → $92 | $87.47 | +5.18% | 15 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $15 | $15.32 | -2.09% | 7 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $108 → $100 | $90.30 | +10.74% | 11 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $315 → $290 | $276.40 | +4.92% | 19 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $40 → $15 | $12.73 | +13.90% | 18 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $118 → $124 | $104.34 | +18.84% | 14 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $559 → $599 | $455.85 | +31.40% | 20 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $27 | $18.40 | +46.74% | 2 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $25 → $9 | $9.42 | -4.46% | 14 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $113 → $98 | $104.26 | -6.00% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $89 | $77.96 | +14.16% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $17 | $9.99 | +70.17% | 1 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $166 → $152 | $178.50 | -14.85% | 13 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $90 → $94 | $76.00 | +23.68% | 9 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $40 → $49 | $15.48 | +216.54% | 2 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $136 | $132.65 | +2.53% | 21 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $70 | $59.62 | +17.41% | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $270 | $190.56 | +41.69% | 5 | Apr 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $54.99 | - | 2 | Nov 2, 2017 |
The Cooper Companies
Aug 28, 2025
Maintains: Overweight
Price Target: $93 → $72
Current: $68.46
Upside: +5.17%
Medtronic
Aug 20, 2025
Maintains: Overweight
Price Target: $98 → $100
Current: $94.25
Upside: +6.10%
Hyperfine
Aug 15, 2025
Maintains: Equal-Weight
Price Target: $0.68 → $0.85
Current: $1.35
Upside: -37.04%
Tandem Diabetes Care
Aug 7, 2025
Maintains: Equal-Weight
Price Target: $20 → $13
Current: $12.79
Upside: +1.64%
Edwards Lifesciences
Aug 7, 2025
Maintains: Overweight
Price Target: $84 → $88
Current: $78.01
Upside: +12.81%
Alcon
Aug 6, 2025
Reinstates: Equal-Weight
Price Target: $93
Current: $79.68
Upside: +16.72%
Inspire Medical Systems
Aug 5, 2025
Maintains: Equal-Weight
Price Target: $174 → $101
Current: $82.80
Upside: +21.98%
Stryker
Aug 1, 2025
Maintains: Overweight
Price Target: $435 → $445
Current: $388.79
Upside: +14.46%
Teleflex
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $137 → $131
Current: $132.50
Upside: -1.13%
Pulmonx
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $6 → $3
Current: $1.69
Upside: +77.51%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $33 → $24
Current: $24.49
Upside: -2.00%
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $86 → $92
Current: $87.47
Upside: +5.18%
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $12 → $15
Current: $15.32
Upside: -2.09%
Jul 31, 2025
Maintains: Overweight
Price Target: $108 → $100
Current: $90.30
Upside: +10.74%
Jul 30, 2025
Maintains: Overweight
Price Target: $315 → $290
Current: $276.40
Upside: +4.92%
Jul 25, 2025
Downgrades: Equal-Weight
Price Target: $40 → $15
Current: $12.73
Upside: +13.90%
Jul 24, 2025
Maintains: Overweight
Price Target: $118 → $124
Current: $104.34
Upside: +18.84%
Jul 23, 2025
Maintains: Overweight
Price Target: $559 → $599
Current: $455.85
Upside: +31.40%
Jul 17, 2025
Maintains: Overweight
Price Target: $28 → $27
Current: $18.40
Upside: +46.74%
Jul 9, 2025
Downgrades: Equal-Weight
Price Target: $25 → $9
Current: $9.42
Upside: -4.46%
May 6, 2025
Maintains: Equal-Weight
Price Target: $113 → $98
Current: $104.26
Upside: -6.00%
May 1, 2025
Maintains: Overweight
Price Target: $103 → $89
Current: $77.96
Upside: +14.16%
Jan 30, 2025
Maintains: Overweight
Price Target: $13 → $17
Current: $9.99
Upside: +70.17%
Jan 23, 2025
Maintains: Equal-Weight
Price Target: $166 → $152
Current: $178.50
Upside: -14.85%
Dec 11, 2024
Maintains: Overweight
Price Target: $90 → $94
Current: $76.00
Upside: +23.68%
Dec 5, 2023
Upgrades: Overweight
Price Target: $40 → $49
Current: $15.48
Upside: +216.54%
Apr 5, 2023
Maintains: Overweight
Price Target: $140 → $136
Current: $132.65
Upside: +2.53%
May 11, 2022
Maintains: Overweight
Price Target: $80 → $70
Current: $59.62
Upside: +17.41%
Apr 8, 2020
Maintains: Overweight
Price Target: $279 → $270
Current: $190.56
Upside: +41.69%
Nov 2, 2017
Upgrades: Outperform
Price Target: n/a
Current: $54.99
Upside: -